Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein

By Butch A.W.   Kelly K.A.   Munshi N.C.  

Experimental Hematology, Vol. 29, Iss. 1, 2001-01 ,pp. : 85-92

Elsevier

Access to resources Recommend Favorite

Efficient presentation of tumor idiotype to autologous T cells by CD83 + dendritic cells derived from highly purified circulating CD14 + monocytes in multiple myeloma patients

By Ratta M.   Curti A.   Fogli M.   Pantucci M.   Viscomi G.   Tazzari P.   Fagnoni F.   Vescovini R.   Sansoni P.   Tura S.   Lemoli R.M.  

Experimental Hematology, Vol. 28, Iss. 8, 2000-08 ,pp. : 931-940

Elsevier

Access to resources Recommend Favorite

GPRC5D is a promising marker for monitoring the tumor load and to target multiple myeloma cells

By Cohen Yossi   Gutwein Odit   Garach-Jehoshua Osnat   Bar-Haim Adina   Kornberg Abraham  

Hematology, Vol. 18, Iss. 6, 2013-11 ,pp. : 347-350

Maney Publishing

Access to resources Recommend Favorite

The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma

By  

Immunity, Inflammation And Disease, Vol. 3, Iss. 2, 2015-06 ,pp. : 94-102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cellular and Humoral Immune Responses Against Autoreactive T cells in Multiple Sclerosis Patients After T cell Vaccination

By Hermans G.   denzer U.   Lohse A.   Raus J.   Stinissen P.  

Journal of Autoimmunity, Vol. 13, Iss. 2, 1999-09 ,pp. : 233-246

Academic Press

Access to resources Recommend Favorite